Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review

Szejtli, 1998, Introduction and general overview of cyclodextrin chemistry, Chem. Rev., 98, 1743, 10.1021/cr970022c Szejtli, 1988 Duchêne, 1991 Albers, 1995, Cyclodextrin derivatives in pharmaceutics, Crit. Rev. Ther. Drug Carr. Syst., 12, 311, 10.1615/CritRevTherDrugCarrierSyst.v12.i4.20 Veiga, 2005, Comparative study on triclosan interactions in solution and in the solid state with natural and chemically modified cyclodextrins, J. Incl. Phenom. Macrocycl. Chem., 53, 77, 10.1007/s10847-005-1047-6 Maestrelli, 2009, Comparative study of oxaprozin complexation with natural and chemically modified cyclodextrins in solution and in the solid state, J. Incl. Phenom. Macrocycl. Chem., 63, 17, 10.1007/s10847-008-9484-7 Mennini, 2014, Physicochemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins, J. Pharm. Biomed. Anal., 89, 142, 10.1016/j.jpba.2013.11.009 Duchene, 1987 Fromming, 1994 Loftsson, 2007, Cyclodextrins and their pharmaceutical applications, Int. J. Pharm., 329, 1, 10.1016/j.ijpharm.2006.10.044 Marques Fernandes, 2003, Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits, J. Control. Release, 88, 127, 10.1016/S0168-3659(02)00465-0 Corti, 2008, Sustained release matrix tablets of metformin hydrochloride in combination with triacetyl-β-cyclodextrin, Eur. J. Pharm. Biopharm., 68, 303, 10.1016/j.ejpb.2007.06.004 Bragagni, 2010, Physical chemical characterization of binary systems of prilocaine hydrochloride with triacetyl-β-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem., 68, 437, 10.1007/s10847-010-9807-3 Mura, 2014, Analytical techniques for characterization of cyclodextrin complexes in solution: a review, J. Pharm. Biomed. Anal., 101, 238, 10.1016/j.jpba.2014.02.022 Mura, 2002, Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide, J. Pharm. Biomed. Anal., 30, 227, 10.1016/S0731-7085(02)00252-2 Cirri, 2004, Solid state characterization of glyburide–cyclodextrin co-ground products, J. Therm. Anal. Calorim., 77, 413, 10.1023/B:JTAN.0000038982.40315.8f Ogawa, 2010, Effects of cogrinding with β-cyclodextrin on the solid state fentanyl, J. Pharm. Sci., 99, 5019, 10.1002/jps.22193 Jug, 2011, Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative, J. Pharm. Biomed. Anal., 54, 1030, 10.1016/j.jpba.2010.12.009 Al-Marzouqi, 2007, Evaluation of supercritical fluid technology as preparative technique of benzocaine–cyclodextrin complexes – comparison with conventional methods, J. Pharm. Biomed. Anal., 43, 566, 10.1016/j.jpba.2006.08.019 Al-Marzouqi, 2007, Physicochemical characterization of drug–cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques, J. Incl. Phenom. Macrocycl. Chem., 57, 223, 10.1007/s10847-006-9192-0 Wen, 2004, Preparation and study of the 1:2 inclusion complex of carvedilol with β-cyclodextrin, J. Pharm. Biomed. Anal., 34, 517, 10.1016/S0731-7085(03)00576-4 Patel, 2007, Preparation and characterization of etoricoxib–beta-cyclodextrin complexes prepared by the kneading method, Acta Pharm., 57, 351, 10.2478/v10007-007-0028-2 Higashi, 2010, Salicylic acid/gamma-cyclodextrin 2:1 and 4:1 complex formation by sealed-heating method, J. Pharm. Sci., 99, 4192, 10.1002/jps.22133 Miletic, 2013, Spray-dried voriconazole–cyclodextrin complexes: solubility, dissolution rate and chemical stability, Carbohydr. Polym., 98, 122, 10.1016/j.carbpol.2013.05.084 Seo, 2010, Release characteristics of freeze-dried eugenol encapsulated with β-cyclodextrin by molecular inclusion method, J. Microencapsul., 27, 496, 10.3109/02652041003681398 Mura, 1999, Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam–cyclodextrin systems, Int. J. Pharm., 179, 117, 10.1016/S0378-5173(98)00390-1 Mura, 1999, Influence of the preparation method on the physicochemical properties of ketoprofen–cyclodextrin binary systems, Drug Dev. Ind. Pharm., 25, 279, 10.1081/DDC-100102172 Cirri, 2009, Influence of the preparation method on the physical–chemical properties of ketoprofen–cyclodextrin–phosphatidylcholine ternary systems, J. Pharm. Biomed. Anal., 50, 690, 10.1016/j.jpba.2008.11.002 Semalty, 2014, Cyclodextrin inclusion complex of racecadotril: effect of drug–β-cyclodextrin ratio and the method of complexation, Curr. Drug Discov. Technol., 11, 154, 10.2174/15701638113106660043 Inoue, 2015, Evaluation of actarit/γ-cyclodextrin complex prepared by different methods, J. Incl. Phenom. Macrocycl. Chem., 81, 161, 10.1007/s10847-014-0445-z Jug, 2010, Preparation and solid state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery, J. Pharm. Biomed. Anal., 52, 9, 10.1016/j.jpba.2009.11.013 Giordano, 2001, Thermal analysis of cyclodextrins and their inclusion compounds, Thermochim. Acta, 380, 123, 10.1016/S0040-6031(01)00665-7 Novak, 2006, Application of combined thermoanalytical techniques in the investigation of cyclodextrin inclusion complexes, J. Therm. Anal. Calorim., 84, 693, 10.1007/s10973-005-7605-8 Giron, 2002, Applications of thermal analysis and coupled techniques in pharmaceutical industry, J. Therm. Anal. Calorim., 68, 335, 10.1023/A:1016015113795 Dodziuk, 2006, Application of differential scanning calorimetry in cyclodextrin and drug studies, 199 Mura, 2003, Differential scanning calorimetry as an analytical tool in the study of drug–cyclodextrin interactions, J. Therm. Anal. Calorim., 73, 635, 10.1023/A:1025494500283 Bettinetti, 2002, Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC, J. Pharm. Biomed. Anal., 30, 1173, 10.1016/S0731-7085(02)00421-1 Zingone, 2005, Preformulation study of the inclusion complex warfarin–β-cyclodextrin, Int. J. Pharm., 291, 3, 10.1016/j.ijpharm.2004.11.013 Wang, 2011, Characterisation of inclusion complex of trans-ferulic acid and hydroxypropyl-β-cyclodextrin, Food Chem., 124, 1069, 10.1016/j.foodchem.2010.07.080 Marzouk, 2010, Comparative evaluation of ketoconazole–β-cyclodextrin systems prepared by coprecipitation and kneading, Drug Discov. Ther., 4, 380 Corciova, 2015, Antibacterial and antioxidant properties of hesperidin: β-cyclodextrin complexes obtained by different techniques, J. Incl. Phenom. Macrocycl. Chem., 81, 71, 10.1007/s10847-014-0434-2 Li, 2005, Inclusion complex of trimethoprim with β-cyclodextrin, J. Pharm. Biomed. Anal., 39, 824, 10.1016/j.jpba.2005.05.011 Ginés, 1998, Determination of the stoichiometry of 2,4-dichloro-phenoxyacetic acid–β-cyclodextrin complexes in solution and in solid state, Thermochim. Acta, 321, 53, 10.1016/S0040-6031(98)00439-0 Bettinetti, 2002, Interaction of naproxen with non-crystalline acetyl-β- and acetyl-γ-cyclodextrins in the solid and liquid state, Eur. J. Pharm. Sci., 15, 21, 10.1016/S0928-0987(01)00199-3 Marques, 1990, Studies of cyclodextrin inclusion complexes: I. The salbutamol–cyclodextrin complex as studied by phase solubility and DSC, Int. J. Pharm., 63, 259, 10.1016/0378-5173(90)90132-N Naidu, 2004, Physicochemical characterization and dissolution properties of meloxicam–cyclodextrin binary systems, J. Pharm. Biomed. Anal., 35, 75, 10.1016/j.jpba.2004.01.003 Pinto, 2005, Physico-chemical characterization of benzocaine–β-cyclodextrin inclusion complexes, J. Pharm. Biomed. Anal., 39, 956, 10.1016/j.jpba.2005.06.010 Figueiras, 2007, Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin, Eur. J. Pharm. Biopharm., 67, 531, 10.1016/j.ejpb.2007.03.005 Chen, 2011, Crassicauline A/β-cyclodextrin host–guest system: preparation, characterization, inclusion mode, solubilization and stability, Carbohydr. Polym., 84, 1321, 10.1016/j.carbpol.2011.01.031 Ma, 2012, Alpinetin/hydroxypropyl-β-cyclodextrin host–guest system: preparation, characterization, inclusion mode, solubilization and stability, J. Pharm. Biomed. Anal., 67, 193, 10.1016/j.jpba.2012.04.038 Yang, 2011, Host–guest system of taxifolin and native cyclodextrin: preparation, characterization, inclusion mode and solubilization, Carbohydr. Polym., 85, 629, 10.1016/j.carbpol.2011.03.029 Wang, 2013, Inclusion of quinestrol and 2,6-di-O-methyl-β-cyclodextrin: preparation, characterization and inclusion mode, Carbohydr. Polym., 93, 753, 10.1016/j.carbpol.2012.12.007 Yang, 2013, Preparation and characterization of inclusion complexes of naringenin with β-cyclodextrin or its derivative, Carbohydr. Polym., 98, 861, 10.1016/j.carbpol.2013.07.010 Bettinetti, 1992, Thermal behavior and dissolution properties of naproxen in combinations with chemically modified β-cyclodextrins, Drug Dev. Ind. Pharm., 18, 39, 10.3109/03639049209043682 Mura, 2002, Comparative study of ibuproxam complexation with amorphous β-cyclodextrin derivatives in solution and in the solid state, Eur. J. Pharm. Biopharm., 54, 181, 10.1016/S0939-6411(02)00075-9 Redenti, 1996, A study on the differentiation between amorphous piroxicam:β-cyclodextrin complex and a mixture of the two amorphous components, Int. J. Pharm., 129, 289, 10.1016/0378-5173(95)04357-8 Van Hees, 2002, Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry, Eur. J. Pharm. Sci., 15, 347, 10.1016/S0928-0987(02)00018-0 Yilmaz, 1995, Thermal decomposition of β-cyclodextrin inclusion complexes of ferrocene and their derivatives, Thermochim. Acta, 261, 107, 10.1016/0040-6031(95)02346-4 Novak, 1998, Investigation of cyclodextrin complexes of mandelic acid, J. Therm. Anal. Calorim., 51, 1039, 10.1007/BF03341483 Meier, 2001, Thermal analysis behavior of β- and γ-cyclodextrin inclusion complexes with capric and caprylic acid, Thermochim. Acta, 375, 153, 10.1016/S0040-6031(01)00514-7 Ishiguro, 1995, Thermogravimetric analysis of cyclodextrin–fatty acid complex formation and its use for predicting suppressed autoxidation of fatty acids, Biosci. Biotechnol. Biochem., 59, 51, 10.1271/bbb.59.51 Garnero, 2010, Studies on trimethoprim–hydroxypropyl-β-cyclodextrin: aggregate and complex formation, Carbohydr. Res., 345, 2550, 10.1016/j.carres.2010.08.018 Garnero, 2012, Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization, J. Pharm. Biomed. Anal., 63, 74, 10.1016/j.jpba.2012.01.011 Garnero, 2014, Improving furosemide polymorphs properties through supramolecular complexes of β-cyclodextrin, J. Pharm. Biomed. Anal., 95, 139, 10.1016/j.jpba.2014.02.017 Bai, 2012, A thermogravimetric analysis (TGA) method developed for estimating the stoichiometric ratio of solid-state α-cyclodextrin-based inclusion complexes, Thermochim. Acta, 541, 62, 10.1016/j.tca.2012.04.029 Veiga, 1998, Interactions of griseofulvin with cyclodextrins in solid binary systems, J. Pharm. Sci., 87, 891, 10.1021/js970233x Ginés-Dorado, 2014, Application of hot stage microscopy to the thermal study of two binary systems of pharmaceutical interest: triamterene–polyethyleneglycol 6000 and triamterene–β-cyclodextrin, vol. 2, 1015 Trollope, 2014, Inclusion of trans-resveratrol in methylated cyclodextrins: synthesis and solid-state structures, J. Org. Chem., 10, 3136 Braga, 2003, Solid state inclusion compound of S-ibuprofen in β-cyclodextrin: structure and characterization, New J. Chem., 27, 597, 10.1039/b207272f Christoforides, 2015, Structural studies of the inclusion complexes of the (+)- and (2)-borneol enantiomers in α- and β-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem., 81, 193, 10.1007/s10847-014-0448-9 Mura, 2001, Interaction of naproxen with crystalline and amorphous methylated β-cyclodextrin in the liquid and in the solid state, Supramol. Chem., 11, 379, 10.1080/10610270108027469 Pralhad, 2004, Study of freeze-dried quercetin–cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis, J. Pharm. Biomed. Anal., 34, 333, 10.1016/S0731-7085(03)00529-6 Aleem, 2008, Effect of β-cyclodextrin and hydroxypropyl-β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir, J. Pharm. Biomed. Anal., 47, 535, 10.1016/j.jpba.2008.02.006 Al-Marzouqi, 2009, Physicochemical properties of antifungal drug–cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques, J. Pharm. Biomed. Anal., 49, 227, 10.1016/j.jpba.2008.10.032 Banchero, 2013, Characterization of ketoprofen/methyl-β-cyclodextrin complexes prepared using supercritical carbon dioxide, J. Chem., 10.1155/2013/583952 He, 2009, Preparation of borneol–methyl-β-cyclodextrin inclusion complex by supercritical carbon dioxide processing, J. Incl. Phenom. Macrocycl. Chem., 65, 249, 10.1007/s10847-009-9575-0 Dang, 2011, Applications of powder X-ray diffraction to inclusion complexes of cyclodextrins, Curr. Org. Chem., 15, 848, 10.2174/138527211794518899 Guo, 2011, Crystal structure determination of the β-cyclodextrin–p-aminobenzoic acid inclusion complex from powder X-ray diffraction data, Carbohydr. Res., 346, 986, 10.1016/j.carres.2011.03.003 Caira, 2011, Structural aspects of crystalline derivatized cyclodextrins and their inclusion complexes, Curr. Org. Chem., 15, 815, 10.2174/138527211794518862 Rezende, 2009, Complexation with β-cyclodextrin confers oral activity on the flavonoid dioclein, Int. J. Pharm., 367, 133, 10.1016/j.ijpharm.2008.09.046 Menezes, 2012, Solid-state β-cyclodextrin complexes containing geraniol, Thermochim. Acta, 548, 45, 10.1016/j.tca.2012.08.023 Salústio, 2009, The influence of the preparation methods on the inclusion of model drugs in a β-cyclodextrin cavity, Eur. J. Pharm. Biopharm., 71, 377, 10.1016/j.ejpb.2008.09.027 Badr-Eldin, 2008, Inclusion complexes of tadalafil with natural and chemically modified β-cyclodextrins. I: Preparation and in-vitro evaluation, Eur. J. Pharm. Biopharm., 70, 819, 10.1016/j.ejpb.2008.06.024 Mora, 2013, Characterization, dissolution and in vivo evaluation of solid acetazolamide complexes, Carbohydr. Polym., 98, 380, 10.1016/j.carbpol.2013.06.012 Fernandes, 2002, Physicochemical characterization and in vitro dissolution behavior of nicardipine–cyclodextrins inclusion compounds, Eur. J. Pharm. Sci., 15, 79, 10.1016/S0928-0987(01)00208-1 Ficarra, 2002, Study of flavonoids/β-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation, J. Pharm. Biomed. Anal., 29, 1005, 10.1016/S0731-7085(02)00141-3 Corti, 2007, Physical–chemical characterization of binary systems of metformin hydrochloride with triacetyl-β-cyclodextrin, J. Pharm. Biomed. Anal., 45, 480, 10.1016/j.jpba.2007.07.018 Jun, 2007, Preparation and characterization of simvastatin/hydroxypropyl-β-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process, Eur. J. Pharm. Biopharm., 66, 413, 10.1016/j.ejpb.2006.11.013 Aigner, 2012, DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding, J. Pharm. Biomed. Anal., 57, 62, 10.1016/j.jpba.2011.08.034 Shan-Yang, 2010, Curve-fitting FTIR studies of loratadine/hydroxypropyl-β-cyclodextrin inclusion complex induced by co-grinding process, J. Pharm. Biomed. Anal., 53, 799, 10.1016/j.jpba.2010.06.010 Liu, 2013, Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex, Food Chem., 141, 900, 10.1016/j.foodchem.2013.03.097 Zhang, 2014, Preparation, characterisation and bioactivity evaluation of the inclusion complex formed between picoplatin and β-cyclodextrin, Carbohydr. Res., 396, 54, 10.1016/j.carres.2014.07.015 Kazarian, 2010, Applications of FTIR spectroscopic imaging in pharmaceutical science Crupi, 2007, UV–vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with β-cyclodextrins, J. Pharm. Biomed. Anal., 44, 110, 10.1016/j.jpba.2007.01.054 Cannavà, 2008, Physicochemical characterization of coumestrol/β-cyclodextrins inclusion complexes by UV–vis and FTIR-ATR spectroscopies, Vib. Spectrosc., 48, 172, 10.1016/j.vibspec.2007.12.013 Stancanelli, 2008, Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with β-cyclodextrin, Bioorg. Med. Chem., 16, 8706, 10.1016/j.bmc.2008.07.085 Cannavà, 2010, Physico-chemical characterization of an amphiphilic cyclodextrin/genistein complex, J. Pharm. Biomed. Anal., 51, 1064, 10.1016/j.jpba.2009.11.025 Cannavà, 2013, Phase-solubility and FTIR-ATR study of idebenone/sulfobutyl ether-cyclodextrin inclusion complex, J. Incl. Phenom. Macrocycl. Chem., 75, 255, 10.1007/s10847-012-0110-3 Venuti, 2014, A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity, Colloids Surf. B, 115, 22, 10.1016/j.colsurfb.2013.11.025 Spivey, 1999, Inclusion complexes of N-benzoyl-d-leucine and N-benzoyl-l-leucine with beta-cyclodextrin by Raman spectroscopy, Appl. Spectrosc., 53, 435, 10.1366/0003702991946893 Arrais, 2009, Raman spectroscopy is a convenient technique for the efficient evaluation of cyclodextrin inclusion molecular complexes of azo-dye colorants and largely polarisable guest molecules, J. Incl. Phenom. Macrocycl. Chem., 64, 73, 10.1007/s10847-009-9538-5 Amado, 2000, Selection of substituted benzaldehyde conformers by the cyclodextrin inclusion process: a Raman spectroscopic study, Raman Spectrosc., 31, 971, 10.1002/1097-4555(200011)31:11<971::AID-JRS627>3.0.CO;2-R Moreira da Silva, 1995, β-Cyclodextrin complexes of benzaldehyde, vanillin and cinnamaldehyde: a Raman spectroscopic study, J. Carbohydr. Chem., 14, 677, 10.1080/07328309508005369 Iliescu, 2004, Raman spectroscopic study of the diclofenac sodium–beta-cyclodextrin interaction, Eur. J. Pharm. Sci., 22, 487, 10.1016/j.ejps.2004.05.003 Yadav, 2009, Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model, AAPS PharmSciTech, 10, 752, 10.1208/s12249-009-9264-8 Mohan, 2012, Water soluble complexes of curcumin with cyclodextrins: characterization by FT-Raman spectroscopy, Vib. Spectrosc., 62, 77, 10.1016/j.vibspec.2012.05.002 López-Tobar, 2012, Encapsulation and isomerization of curcumin with cyclodextrins characterized by electronic and vibrational spectroscopy, Vib. Spectrosc., 62, 292, 10.1016/j.vibspec.2012.06.008 de Oliveira, 2011, Carotenoids and β-cyclodextrin inclusion complexes: Raman spectroscopy and theoretical investigation, J. Phys. Chem. A, 115, 8511, 10.1021/jp2028142 Ikuta, 2014, Spectroscopic studies of R(+)-α-lipoic acid–cyclodextrin complexes, Int. J. Mol. Sci., 15, 20469, 10.3390/ijms151120469 Zoppi, 2013, Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin, AAPS PharmSciTech, 14, 727, 10.1208/s12249-013-9958-9 Dandawate, 2014, Synthesis, characterization, molecular docking and anti-tubercular activity of plumbagin–isoniazid analog and its β-cyclodextrin conjugate, Bioorg. Med. Chem. Lett., 24, 5070, 10.1016/j.bmcl.2014.09.032 Qiu, 2014, Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation, Carbohydr. Polym., 101, 623, 10.1016/j.carbpol.2013.09.035